| Contract & Tender Lead |
Amsterdam |
Netherlands |
International |
Universal Hierarchy Node |
Market Access |
Jul 22, 2025 |
| HEOR Access Evidence Manager, Value Access (f/m/d), Vienna, Austria |
Vienna |
Austria |
International |
Innovative Medicines |
Market Access |
Jul 21, 2025 |
| POS-02168512 Regional Dir, Access and Reimbursement NPS Neuroscience-West-Remote |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 21, 2025 |
| Value & Access Manager |
Gaozhou Guangdong Province |
China |
International |
Innovative Medicines |
Market Access |
Jul 21, 2025 |
| AD, Account Management & Pricing Strategy |
Remote Position USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 17, 2025 |
| Associate Director, Access & Reimbursement (ADAR) - NPS - MS - New England - Remote |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 16, 2025 |
| Director, HEOR International |
Home Worker |
United Kingdom |
International |
Universal Hierarchy Node |
Market Access |
Jul 16, 2025 |
| Director, Market Access Engagement (Multiple Positions) |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 15, 2025 |
| AD, Market Access Engagement (Multiple Positions) |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 15, 2025 |
| Director, Market Access Engagement, Oncology (Multiple Positions) |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 15, 2025 |
| AD, Market Access Engagement, Oncology (Multiple Positions) |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 15, 2025 |
| LDC Commercial Adopt Manager, Pricing and Contracting, Americas |
INSURGENTES |
Mexico |
Operations |
Universal Hierarchy Node |
Market Access |
Jul 15, 2025 |
| Market Access Manager |
Bangkok |
Thailand |
International |
Universal Hierarchy Node |
Market Access |
Jul 14, 2025 |
| ED International V&A CRM |
Basel City |
Switzerland |
Finance |
Innovative Medicines |
Market Access |
Jul 09, 2025 |
| Director International Value & Access, SMA |
Basel City |
Switzerland |
International |
Innovative Medicines |
Market Access |
Jul 07, 2025 |
| Director International Value & Access, Neuroscience Early Pipeline |
Basel City |
Switzerland |
Finance |
Innovative Medicines |
Market Access |
Jul 07, 2025 |
| Head of Access Excellence |
Basel City |
Switzerland |
Finance |
Innovative Medicines |
Market Access |
Jul 04, 2025 |
| Value and Access Head ACC |
Panama |
Panama |
International |
Innovative Medicines |
Market Access |
Jul 04, 2025 |
| Associate Director, Access & Reimbursement (ADAR) - CV - Remote (Charlotte (East), NC |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 03, 2025 |
| ED, Evidence Generation TA Head, Neuroscience |
Remote Position USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 03, 2025 |
| ED, Evidence Generation TA Head - Oncology |
Remote Position USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 03, 2025 |
| ED, Evidence Generation TA Head, CRM |
Remote Position USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 03, 2025 |
| ED, Evidence Generation TA Head, Immunology |
Remote Position USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jul 03, 2025 |
| Regional Access Lead |
Assam |
India |
International |
Universal Hierarchy Node |
Market Access |
Jul 02, 2025 |
| Manager, Healthcare Solutions (Public) |
Makati City |
Philippines |
International |
Innovative Medicines |
Market Access |
Jul 02, 2025 |
| Manager, Healthcare Solutions (Private) |
Makati City |
Philippines |
International |
Innovative Medicines |
Market Access |
Jul 02, 2025 |
| Value & Access Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Market Access |
Jul 01, 2025 |
| Health Care System Manager (m/w/d) RLT, Gebiet: Nord |
Hamburg Novartis Pharma GmbH |
Germany |
International |
Universal Hierarchy Node |
Market Access |
Jun 30, 2025 |
| Patient Navigator in Tempe, AZ or East Hanover, NJ (11:00 a.m. - 8:00 p.m. EST or 9:00 a.m. - 6 p.m. EST) (2 openings) |
Arizona |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jun 26, 2025 |
| AD, Market Access Engagement Operations |
East Hanover |
USA |
US |
Universal Hierarchy Node |
Market Access |
Jun 25, 2025 |
| Patient Centered Outcomes HTA, TA Director (4 open roles) |
London The Westworks |
United Kingdom |
International |
Universal Hierarchy Node |
Market Access |
Jun 24, 2025 |
| RLT Healthcare System Sr. Strategy Lead |
Toranomon NPKK Head Office |
Japan |
International |
Universal Hierarchy Node |
Market Access |
Jun 22, 2025 |
| Field Technical Expert (Radio Ligand Therapy) |
Toranomon NPKK Head Office |
Japan |
International |
Universal Hierarchy Node |
Market Access |
Jun 22, 2025 |
| Strategic Value & Access Manager (w/m/d), Wien, Österreich |
Vienna |
Austria |
International |
Innovative Medicines |
Market Access |
Jun 18, 2025 |
| Regional HTA&Value specialist |
Moscow City |
Russian Fed. |
International |
Innovative Medicines |
Market Access |
Jun 10, 2025 |
| Regional V&A business partner |
Irkutsk |
Russian Fed. |
International |
Innovative Medicines |
Market Access |
Jun 02, 2025 |
| Value & Access Lead |
Riyadh |
Saudi Arabia |
International |
Innovative Medicines |
Market Access |
May 15, 2025 |
| Patient Access Lead Lithuania |
Lithuania |
Lithuania |
International |
Innovative Medicines |
Market Access |
May 13, 2025 |
| HTA Evidence Synthesis Statistician (2 open roles) |
London The Westworks |
United Kingdom |
International |
Universal Hierarchy Node |
Market Access |
Apr 28, 2025 |
| (Sr.) Healthcare Solutions Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Market Access |
Apr 09, 2025 |
| Patient Access Lead |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Mar 27, 2025 |
| AD, Access & Reimbursement RLT - Los Angeles, CA - Remote |
Field Non-Sales USA |
USA |
US |
Universal Hierarchy Node |
Market Access |
Mar 27, 2025 |
| New Products & Strategic Pricing Partner |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |